Organogenesis Holdings Inc - Ordinary Shares - Class A
ORGO
Get informed when a big investor buys or sells
+ FollowMarket Cap$127.8M
Close$
$0.44
55.3% downside
Current Fair Value
55.3% downsideOvervalued by 55.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $127.80 Million |
|---|---|
| Enterprise Value | $148.65 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.16 |
| Beta | 1.27 |
| Outstanding Shares | 128,674,548 |
Return
| Return on Equity | -52.20% |
|---|---|
| Return on Assets | -19.04% |
| Return on Invested Capital | -10.39% |
Valuation & Multiples
| P/E Ratio | -1.21 |
|---|---|
| PEG | -0.13 |
| Price to Sales | 0.33 |
| Price to Book Ratio | 0.5 |
| Enterprise Value to Revenue | 0.32 |
| Enterprise Value to EBIT | -4.09 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | 0.45 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$54.27 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$52.10 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 18,800▼ 49.05% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 52.03%▲ 3.44% |
|---|---|
| Total Invested | $162.65M▲ 10.19% |
| Investors Holding | 137▲ 16.00% |
ESG Score
No data